About Oxford Bioscience Partners
Oxford Bioscience Partners is a Financial Services company based in Boston (United States). Early stage VC firm investing in the US and Korea. It operates on a B2B model. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.
Company details
Early-stage venture capital is provided by Oxford Bioscience Partners, with a focus on life sciences, energy, and healthcare sectors. Operations are centered in Boston, United States, extending investments to companies in the US and Korea. Approximately 1 billion is managed as capital under management. Notable portfolio companies include Gene Logic, HGSI, Cardiome Pharma, Ceres, and Genetic Therapy.
- Headquarters Boston, United States
- SectorsFinancial Services
- Website oxbio.com
Web traffic of Oxford Bioscience Partners
Websites that share an audience with Oxford Bioscience Partners (oxbio.com).
Websites whose visitors overlap most with Oxford Bioscience Partners. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| takadu.com | 90% | 2.4K | #3,087,030 | View details | |
| lexingtonpartners.com | 90% | 10.4K | #1,871,009 | View details | |
| marlinequity.com | 87% | 15.1K | #1,603,754 | View details | |
| centurycap.com | 85% | View details |
Top companies in Venture Capital Funds
3 companies that operate in the same segment as Oxford Bioscience Partners (Venture Capital Funds) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Venture capital firm investing in early-stage tech startups | 1972 | Menlo Park, California, United States | ||||
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | Redwood City, California, United States | USD 691.23 K | |||
Accel is recognized as a leading venture capital firm. | 1983 | Palo Alto, California, United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oxford Bioscience Partners
Complete news archive for Oxford Bioscience Partners
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oxford Bioscience Partners
Oxford Bioscience Partners is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Early-stage venture capital is provided by Oxford Bioscience Partners, with a focus on life sciences, energy, and healthcare sectors. Operations are centered in Boston, United States, extending investments to companies in the US and Korea. Approximately 1 billion is managed as capital under management. Notable portfolio companies include Gene Logic, HGSI, Cardiome Pharma, Ceres, and Genetic Therapy.